Medicure Inc. - Product Pipeline Review - 2014

Date: June 15, 2014
Pages: 27
Price:
US$ 1,500.00 US$ 1,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: MF887C3B50DEN
Leaflet:

Download PDF Leaflet

Summary

Global Markets Direct’s, ‘Medicure Inc. - Product Pipeline Review - 2014’, provides an overview of the Medicure Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medicure Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of Medicure Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Medicure Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Medicure Inc.’s pipeline products
Reasons to buy
  • Evaluate Medicure Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Medicure Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Medicure Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Medicure Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medicure Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Medicure Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Medicure Inc. Snapshot
Medicure Inc. Overview
Key Information
Key Facts
Medicure Inc. - Research and Development Overview
Key Therapeutic Areas
Medicure Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Medicure Inc. - Pipeline Products Glance
Medicure Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Medicure Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Medicure Inc. - Drug Profiles
Tardoxal
Product Description
Mechanism of Action
R&D Progress
MC-45301
Product Description
Mechanism of Action
R&D Progress
MC-45308
Product Description
Mechanism of Action
R&D Progress
tirofiban hydrochloride transdermal
Product Description
Mechanism of Action
R&D Progress
MC-45350
Product Description
Mechanism of Action
R&D Progress
MC-45403
Product Description
Mechanism of Action
R&D Progress
Medicure Inc. - Pipeline Analysis
Medicure Inc. - Pipeline Products by Target
Medicure Inc. - Pipeline Products by Route of Administration
Medicure Inc. - Pipeline Products by Molecule Type
Medicure Inc. - Pipeline Products by Mechanism of Action
Medicure Inc. - Recent Pipeline Updates
Medicure Inc. - Dormant Projects
Medicure Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Medicure Inc., Key Information
Medicure Inc., Key Facts
Medicure Inc. - Pipeline by Indication, 2014
Medicure Inc. - Pipeline by Stage of Development, 2014
Medicure Inc. - Monotherapy Products in Pipeline, 2014
Medicure Inc. - Phase II, 2014
Medicure Inc. - Preclinical, 2014
Medicure Inc. - Discovery, 2014
Medicure Inc. - Pipeline by Target, 2014
Medicure Inc. - Pipeline by Route of Administration, 2014
Medicure Inc. - Pipeline by Molecule Type, 2014
Medicure Inc. - Pipeline Products by Mechanism of Action, 2014
Medicure Inc. - Recent Pipeline Updates, 2014
Medicure Inc. - Dormant Developmental Projects,2014
Medicure Inc., Subsidiaries

LIST OF FIGURES

Medicure Inc. - Pipeline by Top 10 Indication, 2014
Medicure Inc. - Pipeline by Stage of Development, 2014
Medicure Inc. - Monotherapy Products in Pipeline, 2014
Medicure Inc. - Pipeline by Top 10 Target, 2014
Medicure Inc. - Pipeline by Top 10 Route of Administration, 2014
Medicure Inc. - Pipeline by Top 10 Molecule Type, 2014
Medicure Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Skip to top


Osel Inc. - Product Pipeline Review - 2014 US$ 1,125.00 Jul, 2014 · 20 pages
Quest PharmaTech Inc. - Product Pipeline Review - 2015 US$ 1,200.00 Oct, 2015 · 33 pages
Radius Health, Inc. - Product Pipeline Review - 2014 US$ 1,125.00 Aug, 2014 · 29 pages
TissueGene, Inc. - Product Pipeline Review - 2015 US$ 1,200.00 Jul, 2015 · 26 pages

Ask Your Question

Medicure Inc. - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: